Idexx Laboratories | IDXX - Sales Revenues

Stock Price
597.62
Daily Change
22.76 3.96%
Monthly
-2.10%
Yearly
65.53%
Q2 Forecast
552.41

Idexx Laboratories reported $1.09B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Accuray USD 116.17M 14.63M Dec/2024
Align Technology USD 1.05B 54.3M Dec/2025
AngioDynamics USD 79.43M 3.72M Sep/2025
Dentsply International USD 961M 57M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.57B 20M Dec/2025
Fujifilm JPY 857.35B 34.47B Dec/2025
Globus Medical USD 826.4M 57.4M Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Inogen USD 74.93M 504K Sep/2024
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 412.5M 41M Dec/2025
Neogen USD 224.69M 15.5M Sep/2025
Orthofix International USD 219.91M 14.28M Dec/2025
Phibro Animal Health USD 373.91M 10.02M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Steris USD 1.5B 470M Dec/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Zoetis USD 2.4B 0 Dec/2025